A thematic analysis of MDMA-related harm and harm reduction experiences and knowledge in Aotearoa New Zealand

Jai Whelan1, Ryan D Ward2, Geoff Noller3

  • 1Department of Psychology, University of Otago, William James Building, Level 1, 275 Leith Walk, Ōtepoti/Dunedin, Aotearoa, 9016, New Zealand. jai.whelan@postgrad.otago.ac.nz.

PubMed
Abstract

Insights

Understanding Methylenedioxymethamphetamine (MDMA) use in New Zealand shows that mindset, peer support, and drug checking are key harm reduction strategies. This research informs national policies to reduce MDMA-related harm.

Area of Science:

  • Public Health
  • Sociology
  • Drug Policy

Background:

  • Methylenedioxymethamphetamine (MDMA) use is common in Aotearoa New Zealand, with associated harms including fatalities.
  • Despite potential harms, MDMA is considered less harmful than many other widely used substances.
  • Understanding user perspectives is crucial for effective national harm reduction strategies.

Purpose of the Study:

  • To explore MDMA-related harm and harm reduction from the perspective of consumers.
  • To inform national drug policy and harm reduction practices in Aotearoa New Zealand.
  • To reduce overall MDMA-related harm within the community.

Main Methods:

  • Conducted 14 semi-structured focus groups with 60 MDMA users (aged 18-67) in the Southern region of Aotearoa New Zealand.
  • Employed reflexive thematic analysis from a critical realist perspective to analyze user experiences.
  • Focused on gathering insights into perceived harms and effective harm reduction strategies.

Main Results:

  • Identified five key themes: importance of mindset and setting, self-care and moderation, risks associated with polydrug use, protective role of peer support, and the necessity of valid information for self-determination.
  • Highlighted drug checking as an essential harm reduction practice (subtheme 5.1).
  • Revealed that social and informational factors significantly influence MDMA user experiences and safety.

Conclusions:

  • Findings provide critical insights into MDMA consumer experiences and harm reduction needs.
  • Recommendations aim to inform national drug policy and guide harm reduction organizations.
  • The study emphasizes a user-centered approach to minimize MDMA-related harm in Aotearoa New Zealand.

Related Concept Videos

Hallucinogens and Psychedelics01:27

Hallucinogens and Psychedelics

Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
163
An Overview of Psychoactive Drugs01:28

An Overview of Psychoactive Drugs

Psychoactive drugs impact brain function, influencing perception, mood, consciousness, cognition, and behavior. These substances are grouped based on their effects and the mechanisms by which they act.
Stimulants such as cocaine, amphetamines, and nicotine enhance brain activity, leading to increased alertness, attention, and energy. These drugs typically raise heart rate, blood pressure, and body temperature. While they can induce feelings of euphoria, their misuse can result in severe health...
214
Altered States of Awareness01:06

Altered States of Awareness

Altered states of consciousness represent significant deviations from one's normal mental state. These deviations can range from subtle changes in awareness to profound transformations in perception, thought processes, and sensory experiences. Altered states of consciousness can be triggered by various factors, including drug use, meditation, hypnosis, illness, or even intense fatigue.
The ingestion of substances like stimulants or hallucinogens leads to chemical alterations in the brain...
179
Stimulants01:29

Stimulants

Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
187
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
582
Drug Dependence01:17

Drug Dependence

Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.0K